Skip Navigation


Studies




Email This Page Print This Page Change Font Size
Print This Page for Your Doctor


New Search


1 through 2 of 2            Reset Filters 
Sort By:                       Trial Title    |    Age Range    |    Last Updated  
Title begins with...   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z    

 
A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Efficacy Study of Add-on Cladribine Tablet Therapy With Interferon-beta (IFN-b) Treatment in Multiple Sclerosis Subjects With Active Disease (26593)
  • Keyword(s): Multiple Sclerosis, Relapsing forms, Interferon-beta therapy




  • Location:
    • Phoenix, Arizona


  • Status:
    • Active but closed to enrollment
    • Last Updated Thursday, August 13, 2009


  • Age Range
    • 18 and older


  • Summary
    • The goal of this study is to evaluate the safety, tolerability and effectiveness of oral cladribine when taken in combination with Interferon-beta therapy for the treatment of MS.This study will randomize 200 subjects from approximately 50 sites located world-wide, who have experienced at least one relapse while taking Interferon-beta therapy within 48 weeks prior to Screening, irrespective of disability progression. Secondary progressive multiple sclerosis (SPMS) patients, who are still experiencing relapses, and patients who have received disease modifying drugs (DMDs), other than Interferon-beta therapy, during their MS treatment history, but are currently on Interferon-beta therapy and have experienced active MS symptoms (at least 1 relapse) during the 48 weeks prior to Screening, may also be enrolled.Subjects will be randomised in a 2:1 fashion to receive up to 4 cycles of oral cladribine or matching placebo in combination with Interferon-beta therapy. Total subject participation is 104 weeks.


  • Primary Sponsor
    • EMD Serono


  • More Information


 
Read more!
Childbirth May Slow Progression of Multiple Sclerosis  11/24/2009 12:00:00 AM (MST)


Patients who had at least one child were less likely to become disabled, study finds
 
Cilengitide in Subjects With Newly Diagnosed Glioblastoma Multiforme and Unmethylated MGMT Gene Promoter - a Multicenter, Open-label Phase II Study, Investigating Two Cilengitide Regimens in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy). (EMD 121974-012)
  • Keyword(s): Newly diagnosed Glioblastoma multiforme (GBM) (WHO Grade IV)




  • Location:
    • Phoenix, Arizona


  • Status:
    • Open and enrolling subjects
    • Last Updated Monday, February 08, 2010


  • Age Range
    • 18 and older


  • Summary
    • CORE is a Phase II clinical trial in newly diagnosed glioblastoma multiforme (GBM) in patients with an unmethylated promoter of the methylguanine-DNA methyltransferase (MGMT) gene in the tumor tissue. The MGMT gene promoter is a section of DNA that acts as a controlling element for a specific NDA product (MGMT). Methylation of the MGMT gene promoter has been found to appear to be a predictive marker for benefit from temozolomide (TMZ) treatment. In a safety run-in period in dedicated study centers the safety and tolerability of Cilengitide given as an intense treatment in combination with the first part of standard therapy will be assessed. Thereafter the trial will investigate the overall survival and progression-free survival in patients receiving two different regimens of Cilengitide in combination with standard treatment versus standard treatment alone.


  • Primary Sponsor
    • EMD Serono


  • More Information


 
Read more!
Childhood Brain Cancer Causes Other Long-Term Problems  11/2/2009 12:00:00 AM (MST)


Treatment leaves survivors with significant cognitive decline, researchers find
Epilepsy

Epilepsy

We are seeking individuals with epilepsy to participate in research studies at St. Joseph's.

Learn more...


Brain Tumors

Brain Tumors

We are seeking individuals with Brain Tumors to participate in research studies at St. Joseph's.

Learn more...

Browse Trials by Area

We have also organized the clinical trial by area. Hover over the highlighted areas on the map to locate trials in your area.

Click the highlighted areas to find trials

Browse Trials by Conditions

We have also organized the clinical trial by Health Conditions. Choose a condition from the drop-down menu to start your search.

Bottom of Navigation